4/A
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-048859
Chairman and CEO bought 10,000 shares at an average $2.97 ($29,740)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-08-26 | Purchase | +6,000 | $3.19 | $19,140 | 10,189,293 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-27 | Purchase | +4,000 | $2.65 | $10,600 | 10,193,293 | D |
| Open-market purchases · 10,000 sh · avg $2.97 · $29,740 | |||||||
Loading xslF345X03/doc4a.xml…